CA Patent

CA2117351C — Preparation of tablets of increased strength

Assigned to Pfizer Inc · Expires 1998-03-03 · 28y expired

What this patent protects

Tablets of increased strength are manufactured by combining and compressing a meltable binder, excipients and a pharmaceutically active agent into a tablet, melting the binder in the tablet, and then solidifying the binder.

USPTO Abstract

Tablets of increased strength are manufactured by combining and compressing a meltable binder, excipients and a pharmaceutically active agent into a tablet, melting the binder in the tablet, and then solidifying the binder.

Drugs covered by this patent

oxycodone-hydrochloride (OXYCODONE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2117351C
Jurisdiction: CA
Classification: —
Expires: 1998-03-03
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.